Charles Schwab’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.76M | Buy |
578,763
+50,615
| +10% | +$329K | ﹤0.01% | 2456 |
|
|
2025
Q1 | $4.19M | Sell |
528,148
-7,353
| -1% | -$58.3K | ﹤0.01% | 2342 |
|
|
2024
Q4 | $6.78M | Buy |
535,501
+28,053
| +6% | +$355K | ﹤0.01% | 2189 |
|
|
2024
Q3 | $7.07M | Buy |
507,448
+64,700
| +15% | +$901K | ﹤0.01% | 2193 |
|
|
2024
Q2 | $6.1M | Sell |
442,748
-14,904
| -3% | -$205K | ﹤0.01% | 2268 |
|
|
2024
Q1 | $7.56M | Buy |
457,652
+4,718
| +1% | +$77.9K | ﹤0.01% | 2124 |
|
|
2023
Q4 | $6.61M | Buy |
452,934
+5,796
| +1% | +$84.6K | ﹤0.01% | 2195 |
|
|
2023
Q3 | $5.49M | Buy |
447,138
+125,050
| +39% | +$1.53M | ﹤0.01% | 2209 |
|
|
2023
Q2 | $3.85M | Buy |
322,088
+119,421
| +59% | +$1.43M | ﹤0.01% | 2337 |
|
|
2023
Q1 | $2.71M | Sell |
202,667
-1,238
| -0.6% | -$16.6K | ﹤0.01% | 2440 |
|
|
2022
Q4 | $4.39M | Buy |
203,905
+4,953
| +2% | +$107K | ﹤0.01% | 2283 |
|
|
2022
Q3 | $3.99M | Buy |
198,952
+45,909
| +30% | +$920K | ﹤0.01% | 2338 |
|
|
2022
Q2 | $2.74M | Buy |
153,043
+49,009
| +47% | +$877K | ﹤0.01% | 2460 |
|
|
2022
Q1 | $1.03M | Buy |
104,034
+27,866
| +37% | +$277K | ﹤0.01% | 2835 |
|
|
2021
Q4 | $1.28M | Buy |
76,168
+942
| +1% | +$15.9K | ﹤0.01% | 2820 |
|
|
2021
Q3 | $1.79M | Buy |
+75,226
| New | +$1.79M | ﹤0.01% | 2723 |
|